Late-onset Alzheimer's disease: From genetics to biology;Les formes tardives de la maladie d'Alzheimer: De la génétique à la biologie

Medecine/Sciences

Volumn 18, Issue 6-7, 2002, Pages 709-716

  Chartier Harlin, Marie Christine ^a   Araria Goumidi, Louisa ^a   Lambert, Jean Charles ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; CHROMOSOME 10; CHROMOSOME 12; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATION; LIPID METABOLISM; REVIEW; RISK FACTOR;

EID: 0036318262     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/20021867709     Document Type: Review

References (53)

1. Alzheimer's disease in one monozygotic twin
2. Amyloid, the presenilins and Alzheimer's disease
3. Apolipoprotein E: Highavidity binding to betaamyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
4. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13.2 chromosomal region
5. Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex
6. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis
7. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4
8. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease
9. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals
10. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
11. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
12. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain
13. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease
14. Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease
15. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease
16. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia
17. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease
18. Contribution of APOE prmoter polymorphisms to Alzheimer's disease risk
19. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene
20. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
21. Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - The ECTIM study
22. Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease
23. Neuropathological epidemiology of cerebral aging: A study of two genetic polymorphisms
24. Dietary fat intake and the risk of incident dementia in the Rotterdam study
25. A fluid connection: Cholesterol and Abeta
26. Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(SW) mice
27. A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease
28. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro
29. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
30. Microglial activation in Alzheimer disease: Association with APOE genotype
31. Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury
32. Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein
33. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides
34. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease
35. Neurite degeneration elicited by apolipoprotein E peptides
36. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12
37. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
38. A full genome scan for late onset Alzheimer's disease
39. Genetic studies on chromosome 12 in lateonset Alzheimer disease
40. Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity
41. The transcriptional factor LBP1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease
42. The human FE65 gene: Genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type
43. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60
44. The alpha2-macroglobulin gene in AD: A population-based study and meta-analysis
45. Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
46. Allelic association between the D10S1423 marker and Alzheimer's disease in a German population
47. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution
48. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees
49. Identification of novel genes in late-onset Alzheimer's disease
50. Susceptibility locus for Alzheimer's disease on chromosome 10
51. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q
52. Les protéases impliquées dans la dégradation du peptide Aβ sont-elles des facteurs de risque pour la maladie d'Alzheimer?
53. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease